ResearcherMayo ClinicActive in the last 2 years
Jeremy D. Kratz
Matched on ORCID iD 0000-0003-1979-3955; OpenAlex author ID A5021338173, A5158608568. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2025: 2 papers · 2026: 2 papers
Papers 4
- Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resection for pancreatic ductal adenocarcinoma: … Co-author DOI 10.1007/s12094-026-04564-6↗
- SPINK1-COL18A1 crosstalk shapes epigenome and drives cancer stemness in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2026.117806↗
- Immune-Based Therapies in Pancreatic Cancer: a Systematic Review of Ongoing Clinical Trials (2020-2022). Last author DOI 10.1007/s12029-025-01194-z↗
- Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patients With Resectable Pancreatic Cancer: Su… Co-author DOI 10.1016/j.prro.2025.01.011↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Noelle K. LoConte · 2 shared papers, 2025 · strength 0.51
- Paper Immune-Based Therapies in Pancreatic Cancer: a Systematic Review of Ongoing Clinical Trials (2020-2022). DOI 10.1007/s12029-025-01194-z↗
- Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗
- Syed Nabeel Zafar · 2 shared papers, 2025–2026 · strength 0.49
- Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
- Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗
- Justine T. Hung · 1 shared paper, 2025 · strength 0.30
- Clayton Thomas Marcinak · 1 shared paper, 2026 · strength 0.29
- Alexandra W. Acher · 1 shared paper, 2026 · strength 0.29
- Benjamin A. Y. Cher · 1 shared paper, 2026 · strength 0.29
- Muhammad Maisam Ali · 1 shared paper, 2026 · strength 0.29
- Md Shahadat Hossan · 1 shared paper, 2026 · strength 0.21
- Haoyu Tang · 1 shared paper, 2026 · strength 0.21
- John W. Kunstman · 1 shared paper, 2026 · strength 0.21
- Ankit Chhoda · 1 shared paper, 2026 · strength 0.21
- Saryn Doucette · 1 shared paper, 2026 · strength 0.21
- Laura DeLong Wood · 1 shared paper, 2026 · strength 0.21
- Christopher Lee Wolfgang · 1 shared paper, 2026 · strength 0.21
- Nita Ahuja · 1 shared paper, 2026 · strength 0.21
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2026 · strength 0.21
- Michael Frederick Bassetti · 1 shared paper, 2025 · strength 0.20
- Sean M. Ronnekleiv‐Kelly · 1 shared paper, 2025 · strength 0.20
- Daniel Erik Abbott · 1 shared paper, 2025 · strength 0.20
- Jacob S. Witt · 1 shared paper, 2025 · strength 0.20
- Sharon Marie Weber · 1 shared paper, 2025 · strength 0.20
- Mustafa M. Basree · 1 shared paper, 2025 · strength 0.20
- Nataliya Volodymyrivna Uboha · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.